Latest Licensing News

Arovella Therapeutics has named Dr Nicole Van Der Weerden as acting CEO following Dr Michael Baker’s departure, positioning her to steer the company through the critical phase I trial of its CAR-iNKT therapy ALA-101.

BrainChip detailed significant progress in its neuromorphic AI technology and commercial strategy at its 2026 AGM, highlighting the AKD1500 chip launch and expanding defense and industrial collaborations.

dorsaVi has initiated its Ultra-Edge Modular Design program, transitioning from IP development to a manufacturable hardware platform targeting robotics, exoskeletons, and industrial AI with ultra-low power consumption.

Aerometrex expands its MetroMap Partner Program, adding new industry partners and unlocking uncapped revenue growth beyond its foundational Landchecker deal.

Emerald Resources has cleared the final regulatory hurdle for its Dingo Range Gold Project and committed A$30 million to critical equipment purchases, underpinning its ambition to become a multi-mine gold producer across Australia and Cambodia.

Entropy Neurodynamics has bolstered its intellectual property portfolio with a new US provisional patent application for TRP-8803, following compelling Phase 2a data showing a 75% response rate in treatment-resistant IBS patients.

Galileo Mining has identified compelling geophysical targets at its Norseman project, setting the stage for a 5,000-metre drilling campaign focused on sulphide mineralisation at Mission Sill and Callisto South.

Nine Entertainment’s acquisition of QMS Media and sale of Nine Radio mark a strategic pivot, with strong Q3 digital and subscription revenue growth cushioning a cautious Q4 advertising environment.

Holista Colltech has partnered with Swang Chai Chuan to develop a nano-collagen production facility in Western Australia, marking a major step in commercialising its collagen technology with a $1.6 million initial investment.

Sigma Healthcare reports robust growth in Chemist Warehouse sales across Australia and internationally, announces a joint venture to enter the UK market, and secures a major distribution centre lease in New Zealand to support its expanding network.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Arovella Therapeutics undergoes a major board overhaul and CEO resignation following a shareholder push, as the company embarks on a strategic review of its cell therapy platform.